Clinical Trial Update: Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating tetanus immunization in individuals with no immunization history or sub-protective antibody levels was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tetanus

Drugs mentioned

• Tetanus vaccine (tetanus toxoid) (tetanus toxoid vaccine)

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Tetanus | Phase 4 | Status: TERMINATED